Preemptive therapy with gancyclovir for early high-risk CMV infection allows effective treatment with antithymocyte globulin of steroid-resistant rejection after renal transplantation

Transplant Proc. 1993 Feb;25(1 Pt 2):1436-8.

Authors

W J van Son¹, A P van den Berg, T H The, A M Tegzess

Affiliation

¹ Department of Internal Medicine, University Hospital, Groningen, The Netherlands.

PMID: 8382873

No abstract available

MeSH terms

Adult
Antilymphocyte Serum / therapeutic use*
Cyclosporine / therapeutic use
Cytomegalovirus Infections / diagnosis
Cytomegalovirus Infections / physiopathology
Cytomegalovirus Infections / prevention & control*
Drug Resistance
Female
Ganciclovir / therapeutic use*
Graft Rejection / immunology
Graft Rejection / therapy*
Humans
Immunoglobulin G / blood
Immunoglobulin M / blood
Kidney Transplantation / immunology*
Male
Middle Aged
Muromonab-CD3 / therapeutic use
Prednisolone / therapeutic use
Retrospective Studies

Substances

Antilymphocyte Serum
Immunoglobulin G
Immunoglobulin M
Muromonab-CD3
Cyclosporine
Prednisolone
Ganciclovir